Cumberland Pharmaceuticals, Inc. (CPIX)
| Market Cap | 39.88M |
| Revenue (ttm) | 39.10M |
| Net Income (ttm) | 29,876 |
| Shares Out | 14.98M |
| EPS (ttm) | 0.00 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 12,102 |
| Open | 2.68 |
| Previous Close | 2.67 |
| Day's Range | 2.62 - 2.68 |
| 52-Week Range | 2.58 - 3.94 |
| Beta | 0.24 |
| Analysts | Strong Buy |
| Price Target | 8.50 (+217.2%) |
| Est. Earnings Date | Nov 9, 2021 |
About CPIX
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and rheumatology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative, for the treatment of chronic and acute constipation; Omeclamox-Pak for the treatment of Helicobacter pylo...
Financial Performance
In 2020, CPIX's revenue was $37.44 million, an increase of 8.88% compared to the previous year's $34.39 million. Losses were -$3.34 million, -5.61% less than in 2019.
Financial StatementsAnalyst Forecast
According to one analyst, the rating for CPIX stock is "Strong Buy" and the 12-month stock price forecast is 8.50.
News
Cumberland Pharmaceuticals Launches RediTrex® Product Line For Active Rheumatoid, Juvenile Idiopathic And Severe Psor...
NASHVILLE, Tenn., Sept. 29, 2021 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, announced today the national launch of its RediTrex ® (methotrexate) ...
Cumberland Pharmaceuticals (CPIX) Reports Break-Even Earnings for Q2
Cumberland (CPIX) delivered earnings and revenue surprises of 100.00% and 5.66%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Cumberland Pharmaceuticals Reports Second Quarter 2021 Financial Results & Company Update
NASHVILLE, Tenn., Aug. 10, 2021 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today is providing a company update and second quarter 2021 financial ...
Earnings Preview: Cumberland
Cumberland (NASDAQ:CPIX) announces its next round of earnings this Tuesday, August 10. Here is Benzinga's everything-that-matters guide for this Tuesday's Q2 earnings announcement.
Earnings Preview: Cumberland Pharmaceuticals (CPIX) Q2 Earnings Expected to Decline
Cumberland (CPIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cumberland Pharmaceuticals To Announce Second Quarter 2021 Financial Results
NASHVILLE, Tenn., Aug. 3, 2021 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release second quarter 2021 financial results and provide a Company update afte...
Cumberland Pharmaceuticals Reports 2.5M Patient Doses Delivered, No Product Recalls, No FDA Issues in 2020
NASHVILLE, Tenn., July 26, 2021 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today released its 2020 Sustainability Report, which details the compa...
4 Small Drug Stocks Set to Escape the COVID-Led Industry Weakness
4 Small Drug Stocks Set to Escape the COVID-Led Industry Weakness
Vibativ® Effectively Helps Treat Secondary Bacterial Infections In COVID-19 Patients
NASHVILLE, Tenn., June 21, 2021 /PRNewswire/ --Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today released a series of case reports describing the effectiveness of...
Is Cumberland (CPIX) a Solid Growth Stock? 3 Reasons to Think " Yes "
Cumberland (CPIX) could produce exceptional returns because of its solid growth attributes.
Cumberland Pharmaceuticals Names John Hamm New Chief Financial Officer
NASHVILLE, Tenn., May 19, 2021 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, announced today that it has promoted John Hamm to Director Finance & A...
Cumberland: Q1 Earnings Insights
Shares of Cumberland (NASDAQ:CPIX) moved higher in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 600.00% over the past year to $0.07, which b...
Cumberland Pharmaceuticals Reports First Quarter 2021 Financial Results & Company Update
NASHVILLE, Tenn., May 11, 2021 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today is providing a company update and first quarter 2021 financial re...
Preview: Cumberland's Earnings
Cumberland (NASDAQ:CPIX) announces its next round of earnings this Tuesday, May 11. Here is Benzinga's look at Cumberland's Q1 earnings report.
Cumberland Pharmaceuticals To Announce First Quarter 2021 Financial Results
NASHVILLE, Tenn., May 4, 2021 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release first quarter 2021 financial results and Company update after the market...
Providence's Tegria adds another company, acquires healthcare consulting firm Cumberland
Seattle-based Tegria, a healthcare services and tech company that Providence launched last year, announced the acquisition of Franklin, Tenn.
Cumberland Pharmaceuticals (CPIX) Beats Q4 Earnings and Revenue Estimates
Cumberland (CPIX) delivered earnings and revenue surprises of 200.00% and 4.93%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Recap: Cumberland Q4 Earnings
Shares of Cumberland (NASDAQ:CPIX) moved higher in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share fell 88.89% over the past year to $0.01, which beat th...
Cumberland Pharmaceuticals Reports 9% Revenue Growth In 2020
NASHVILLE, Tenn., March 9, 2021 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care, gastroenterology and rheumatology, toda...
Cumberland Earnings Preview
Cumberland (NASDAQ:CPIX) announces its next round of earnings this Tuesday, March 09. Here is Benzinga's look at Cumberland's Q4 earnings report.
Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2020 Financial Results
NASHVILLE, Tenn., March 2, 2021 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release fourth quarter and annual 2020 financial results and Company update af...
Introducing RediTrex®, A New Methotrexate Delivery System
NASHVILLE, Tenn., Nov. 17, 2020 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a U.S. specialty pharmaceutical company, announced today the launch of RediTrex® (methotrexate) injection....
Cumberland Pharmaceuticals, Inc. (CPIX) CEO A. J. Kazimi on Q3 2020 Results - Earnings Call Transcript
Cumberland Pharmaceuticals, Inc. (CPIX) CEO A. J. Kazimi on Q3 2020 Results - Earnings Call Transcript
Cumberland Pharmaceuticals (CPIX) Q3 Earnings and Revenues Surpass Estimates
Cumberland (CPIX) delivered earnings and revenue surprises of 128.57% and 7.45%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?